Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia.

Trial Profile

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Dec 2011

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Torticollis
  • Focus Adverse reactions
  • Most Recent Events

    • 15 Dec 2011 Actual patient number changed from 28 to 145 as reported by ClinicalTrials.gov (Parent trial: NCT00528541).
    • 15 Dec 2011 Actual patient number changed from 28 to 145 as reported by ClinicalTrials.gov (Parent trial: NCT00528541).
    • 15 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov (Parent trial: NCT0052854).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top